HCM
NASDAQ
HK
HUTCHMED (China) Limited - American Depositary Shares
$15.42
▲ +$0.28
(+1.85%)
Vol 36K
12
Quality Score
ok
Deep Check
2/5
ok
Rev ✓
NI ✓
>IPO ✗
Mkt Cap
$18.0B
P/E
5.0
ROE
37.0%
Margin
77.5%
D/E
7.60
Beta
0.91
52W
$18–$31
Wall Street Consensus
27 analysts · Apr 202610
Strong Buy
14
Buy
2
Hold
1
Sell
0
Strong Sell
88.9%
Buy Rating
Price Chart
Similar Stocks
Earnings
Beat rate: 100.0%| Quarter | EPS Est | EPS Act | Surprise |
|---|---|---|---|
| Jun 2023 | $-0.38 | $0.19 | +$0.57 |
| Dec 2021 | $-1.06 | $-0.26 | +$0.80 |
| Jun 2021 | $-0.77 | $-0.14 | +$0.63 |
| Dec 2020 | $-0.44 | $-0.11 | +$0.33 |
Fundamentals Trend
| Metric | 2025-06-30 | 2025-09-02 | 2025-10-02 | 2025-11-03 | 2025-12-03 | 2026-01-02 |
|---|---|---|---|---|---|---|
| ROE (TTM) | 37.0% | 37.0% | 37.0% | 37.0% | 37.0% | 37.0% |
| P/E (TTM) | — | 6.19 | 6.03 | 5.50 | 5.44 | 4.95 |
| Net Margin | 163.8% | 77.5% | 77.5% | 77.5% | 77.5% | 77.5% |
| Gross Margin | 39.6% | 44.1% | 44.1% | 44.1% | 44.1% | 44.1% |
| D/E Ratio | 7.60 | 7.60 | 7.60 | 7.60 | 7.60 | 7.60 |
| Current Ratio | 4.65 | 4.65 | 4.65 | 4.65 | 4.65 | 4.65 |
Key Ratios
ROA (TTM)
25.6%
P/S (TTM)
3.84
EPS (TTM)
$0.54
Rev Growth 3Y
+21.0%
52W High
$30.75
52W Low
$18.36
$18.36
52-Week Range
$30.75
Financial Health
Net Debt
$26.6M
Cash
$71.3M
Total Debt
$97.9M
As of Dec 31, 2025
How does HCM compare to Pharmaceuticals peers?
Peer group: Large-cap Pharmaceuticals ($10B+) · 7 companies
HCM valuation vs Pharmaceuticals peers
P/E ratio
5.0
▼
73%
below
peers
(18.2)
vs Peers
vs Industry
Undervalued
P/S ratio
3.8
▲
21%
above
peers
(3.2)
vs Peers
vs Industry
Pricier
P/B ratio
—
▼
0%
below
peers
(2.0)
vs Peers
vs Industry
Overvalued
Div yield
—
▼
0%
below
peers
(3.1%)
vs Peers
vs Industry
In line
HCM profitability vs Pharmaceuticals peers
ROE
37.0%
▲
219%
above
peers
(11.6%)
vs Peers
vs Industry
Top tier
Net margin
77.5%
▲
321%
above
peers
(18.4%)
vs Peers
vs Industry
Top tier
Gross margin
44.2%
▼
39%
below
peers
(72.3%)
vs Peers
vs Industry
Weak
ROA
25.6%
▲
516%
above
peers
(4.2%)
vs Peers
vs Industry
Top tier
HCM financial health vs Pharmaceuticals peers
D/E ratio
7.6
▼
89%
below
peers
(71.1)
vs Peers
vs Industry
Low debt
Current ratio
4.7
▲
182%
above
peers
(1.7)
vs Peers
vs Industry
Strong liquidity
Beta
0.9
▲
5%
above
peers
(0.9)
vs Peers
vs Industry
Less volatile
HCM fundamentals radar
HCM
Peer median
Industry
HCM profitability vs leverage
Bubble size = market cap · X = net margin · Y = D/E ratio
HCM vs peers: key metrics
Top Holders
Top 5: 2.34%Schroder Investment Managem…
1.31%
$32.8M
Allianz Asset Management Gm…
0.52%
$13.1M
State Street Corporation
0.18%
$4.6M
Aia Group Ltd
0.18%
$4.5M
M&G Plc
0.15%
$3.7M
As of Dec 31, 2025
Latest News
No related news yet